Evaluation of the effect of an antiretroviral drug in patients infected with HTLV-1.

Phase 2

Recruiting

• Conditions: Human T-lymphotropic virus 1; B04

• Registration Number: RBR-5x7ccxp
• Lead Sponsor: Fundação Bahiana de Infectologia - FBA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-02-11
• Last Update Posted: 29 May 2023
• Study Completion: 2024-07-04

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Volunteers aged over 18 years, of both genders, have been diagnosed (by Western blot or PCR) with HTLV-1; not present neurological or cognitive deficits that interfere in the performance of any of the proposed activities.

Exclusion Criteria

Subjects with current HIV, HCV (RNA positive) and HBV (HBsAg positive) infection; Active tuberculosis; Corticosteroid use in the last 30 days; End-stage renal disease (hemodialysis); Cancer; Autoimmune diseases; Wheelchair restricted individuals; Subjects who voluntarily request withdrawal from the study; that do not adapt to the proposed protocols.

Study & Design

• Study Type: Intervention
• Study Design: Not specified